» Articles » PMID: 21982447

Separation Science is the Key to Successful Biopharmaceuticals

Overview
Journal J Chromatogr A
Publisher Elsevier
Specialty Chemistry
Date 2011 Oct 11
PMID 21982447
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The impact of economic change, advances in science, therapy and production processes resulted in considerable growth in the area of biopharmaceuticals. Progress in selection of microorganisms and improvements in cell culture and bioreactors is evidenced by increased yields of the desired products in the complex fermentation mixture. At this stage the downstream process of extraction and purification of the desired biopharmaceutical requires considerable attention in the design and operation of the units used for preparative chromatography. Understanding of the process, optimization of column design and experimental conditions have become critical to the biopharmaceutical industry in order to minimize production costs while satisfying new regulatory requirements. Optimization of the purification of biopharmaceuticals by preparative liquid chromatography including an examination of column preparation and bed properties is the focus of this manuscript.

Citing Articles

Recent advances in analytical techniques for high throughput experimentation.

Vervoort N, Goossens K, Baeten M, Chen Q Anal Sci Adv. 2024; 2(3-4):109-127.

PMID: 38716456 PMC: 10989611. DOI: 10.1002/ansa.202000155.


Risk control of host cell proteins in one therapeutic antibody produced by concentrated fed-batch (CFB) mode.

Lu Y, Lin J, Bian T, Chen J, Liu D, Ma M Eng Life Sci. 2023; 23(3):e2200060.

PMID: 36874608 PMC: 9978904. DOI: 10.1002/elsc.202200060.


Prediction of peptides retention behavior in reversed-phase liquid chromatography based on their hydrophobicity.

Al Musaimi O, Valenzo O, Williams D J Sep Sci. 2022; 46(2):e2200743.

PMID: 36349538 PMC: 10098489. DOI: 10.1002/jssc.202200743.


Mapping the molecular basis for growth related phenotypes in industrial producer CHO cell lines using differential proteomic analysis.

Bryan L, Henry M, Kelly R, Frye C, Osborne M, Clynes M BMC Biotechnol. 2021; 21(1):43.

PMID: 34301236 PMC: 8305936. DOI: 10.1186/s12896-021-00704-8.


Interferon-Based Biopharmaceuticals: Overview on the Production, Purification, and Formulation.

Castro L, Lobo G, Pereira P, Freire M, Neves M, Pedro A Vaccines (Basel). 2021; 9(4).

PMID: 33915863 PMC: 8065594. DOI: 10.3390/vaccines9040328.